Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 25Leukemia 13Neuroblastoma 12Myelodysplastic Syndromes 12Multiple Myeloma 12Recurrence 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 8Sarcoma 7Medulloblastoma 7Astrocytoma 7Lymphoma, Non-Hodgkin 6Wilms Tumor 5Osteosarcoma 5Central Nervous System Neoplasms 5Brain Neoplasms 5Sarcoma, Ewing 4Rhabdoid Tumor 4Retinoblastoma 4Optic Nerve Glioma 4Neoplasms 4Myeloproliferative Disorders 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Hodgkin Disease 4Hematologic Neoplasms 4Burkitt Lymphoma 4Testicular Neoplasms 3

Interventions

Cyclophosphamide 12fludarabine 10fludarabine phosphate 7Radiotherapy 6Mycophenolic Acid 6Whole-Body Irradiation 5Sirolimus 5Filgrastim 5Tacrolimus 4Melphalan 4Busulfan 4Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Cyclosporine 3Thiotepa 2Stem Cell Transplantation 2Specimen Handling 2Rituximab 2Methotrexate 2Mesna 2Granulocyte Colony-Stimulating Factor 2Etoposide 2venetoclax 1siplizumab 1rasburicase 1prostaglandin D2 receptor 1milatuzumab 1itacitinib 1eritoran 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Graft vs Host Disease × Granulocyte Colony-Stimulating Factor × Clear all
NCT03018223 2021-09-16

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
32 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT02423915 2021-01-08

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

M.D. Anderson Cancer Center

Phase 1 Completed
5 enrolled
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡